The Rabbit Polyclonal anti-MAGEA4 antibody has been validated for WB, ELISA, IHC (p) and IF. It is suitable to detect MAGEA4 in samples from Human, Rat and Mouse.
Catalog No. ABIN6992141
Quick Overview for MAGEA4 antibody (N-Term) (ABIN6992141)
MAGEA4 antibody is human specific. At least four isoforms of MAGEA4 are known to exist.
Purification
MAGEA4 antibody is affinity chromatography purified via peptide column.
Immunogen
MAGEA4 antibody was raised against a 16 amino acid peptide near the amino terminus of human MAGEA4. The immunogen is located within the first 50 amino acids of MAGEA4.
MAGEA4
Reactivity: Human
WB
Host: Mouse
Polyclonal
unconjugated
Application Notes
MAGEA4 antibody can be used for detection of MAGEA4 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples, Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
MAGEA4 antibody is supplied in PBS containing 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,4 °C
Storage Comment
MAGEA4 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
MAGEA4
(Melanoma Antigen Family A, 4 (MAGEA4))
Alternative Name
MAGEA4
Background
MAGEA4 is a member of the melanoma-associated antigen family that consists of a number of antigens recognized by cytotoxic T lymphocytes (1). MAGEA4 may serve as a target for antitumoral vaccination and may play a role in embryonal development and tumor transformation or aspects of tumor progression. It is expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma and have been implicated in some hereditary disorders, such as dyskeratosis congenital (2-4).